Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeic Acid + High-Dose Dexamethasone in Adult Primary ITP
NCT02556814Phase 4Completed
- Sponsor
- Shandong University
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of caffeic acid in immune thrombocytopenia (ITP), sponsored by Shandong University. Started Sep 2015; status: completed.
02
Drugs
caffeic acid
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT02556814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556814.